title: Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
authors.affiliation: Hôpital Saint-Louis, Paris, France. Electronic address: christian.gisselbrecht@sls.aphp.fr.
authors.forename: Christian
authors.initials: C
authors.lastname: Gisselbrecht
authors.affiliation: University Hospital of Cologne, Cologne, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Borchmann
authors.affiliation: Aarhus University Hospital, Aarhus, Denmark.
authors.forename: Francesco
authors.initials: F
authors.lastname: D'Amore
authors.affiliation: Manchester University, Manchester, UK.
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Illidge
authors.affiliation: University of Bologna, Bologna, Italy.
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
mesh_terms: D019008:Drug Resistance, Neoplasm; D006689:Hodgkin Disease / Q000378:metabolism / Q000628:therapy; D006801:Humans; D017730:Ki-1 Antigen / Q000378:metabolism*; D008223:Lymphoma / Q000378:metabolism* / Q000628:therapy*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000378:metabolism / Q000628:therapy; D058990:Molecular Targeted Therapy / Q000379:methods* / Q000639:trends*; D012008:Recurrence
chemical_list: D017730:Ki-1 Antigen